Spots Global Cancer Trial Database for Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
Official Title: Trabectedin Combined With Regional Hyperthermia as Second Line Treatment for Adult Patients With Advanced Soft-tissue Sarcoma
Study ID: NCT02359474
Conditions
Study Description
Brief Summary: This trial compares trabectedin alone to trabectedin in combination with regional hyperthermia in patients with high-risk soft tissue sarcoma. The study is designed to demonstrate a significant benefit for sarcoma-therapy by adding regional hyperthermia.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ludwig-Maximilians University of Munich, Klinikum Großhadern, Munich, Bavaria, Germany
Helios Klinikum Bad Saarow, Bad Saarow, , Germany
Charité - Universitätsmedizin Berlin, Berlin, , Germany
Helios Klinikum Berlin-Buch, Berlin, , Germany
Universitätsklinikum Erlangen, Erlangen, , Germany
Contact Details
Name: Rolf Issels, MD
Affiliation: Ludwig-Maximilians - University of Munich
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
